Koninklijke Philips N.V. NY Registry Shares (PHG) vs Zimmer Biomet (ZBH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Zimmer Biomet (ZBH) has outperformed Koninklijke Philips N.V. NY Registry Shares (PHG) over the past year, losing 10.7% versus a loss of 13.4%. Over five years, ZBH leads with a -37.7% price change compared with -46.0% for PHG. Koninklijke Philips N.V. NY Registry Shares is the larger company by market cap ($23.75 billion vs $16.95 billion), about 1.4 times the size.
On valuation, Zimmer Biomet trades at a lower forward P/E (9.8x vs 12.8x for Koninklijke Philips N.V. NY Registry Shares). Koninklijke Philips N.V. NY Registry Shares offers the higher dividend yield (3.50% vs 1.08%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PHG | ZBH |
|---|---|---|
| Share price | $24.30 | $88.88 |
| Market cap | $23.75B | $16.95B |
| 1-day change | +0.87% | +0.44% |
| YTD return | -11.04% | -1.59% |
| 1-year return | -13.44% | -10.67% |
| 5-year return | -45.95% | -37.73% |
| P/E ratio (TTM) | 18.13 | 21.57 |
| Forward P/E | 12.83 | 9.80 |
| EPS (TTM) | $1.34 | $4.12 |
| Dividend yield | 3.50% | 1.08% |
| Annual dividend | $0.85 | $0.96 |
| Revenue (latest FY) | — | $8.23B |
| Revenue growth (YoY) | — | +7.20% |
| Net income (latest FY) | — | $705.10M |
| Gross margin | — | 69.71% |
| Operating margin | — | 13.34% |
| Net margin | — | 8.57% |
| 52-week high | $33.44 | $106.88 |
| 52-week low | $23.62 | $79.12 |
| Distance from 52-week high | -27.33% | -16.84% |
| Analyst consensus | hold | buy |
| Avg. price target upside | +31.77% | +20.65% |
| Average volume | 994.93K | 2.16M |
| Shares outstanding | 977.43M | 190.74M |
| Employees | 63,670 | 17,000 |
| Sector | Health Care | Health Care |
| Industry | Medical Electronics | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Koninklijke Philips N.V. NY Registry Shares offers a meaningfully higher dividend yield (3.50% vs 1.08%).
About Koninklijke Philips N.V. NY Registry Shares
PHG stock →Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
Health Care · Medical Electronics · 63,670 employees
About Zimmer Biomet
ZBH stock →Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.
Health Care · Industrial Specialties · 17,000 employees
PHG vs ZBH FAQ
Which is bigger, Koninklijke Philips N.V. NY Registry Shares or Zimmer Biomet?
Koninklijke Philips N.V. NY Registry Shares (PHG) is larger, with a market capitalization of $23.75B compared with $16.95B for Zimmer Biomet (ZBH).
Which stock has performed better over the past year, PHG or ZBH?
ZBH returned -10.67% over the past 12 months, compared with -13.44% for PHG (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, PHG or ZBH?
PHG has the lower trailing P/E at 18.1, versus 21.6 for ZBH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Koninklijke Philips N.V. NY Registry Shares or Zimmer Biomet?
Koninklijke Philips N.V. NY Registry Shares has the higher yield at 3.50%, compared with 1.08% for Zimmer Biomet.
Are Koninklijke Philips N.V. NY Registry Shares and Zimmer Biomet in the same industry?
Both are in the Health Care sector, but in different industries: Medical Electronics for Koninklijke Philips N.V. NY Registry Shares and Industrial Specialties for Zimmer Biomet.